company

XU MEDICAL AS

2318 HAMAR

Return on Equity
152,62 %
Current Ratio
1,26
Debt-to-Equity Ratio
0,31
Key figures (NOK)2022
Revenue6 568 000
Net Income1 459 000
Total Assets5 093 000
Total Equity956 000
Income (NOK)2022
Revenue6 568 000
Expenditure4 687 000
Operating Profit1 881 000
Financial Income1 000
Financial Costs12 000
Financial Balance−11 000
Earnings Before Tax1 870 000
Tax411 000
Net Income1 459 000
Balance (NOK)2022
Total Fixed Assets266 000
Total Current Assets4 827 000
Total Assets5 093 000
Total Retained Equity856 000
Total Equity956 000
Total Long-Term Debt300 000
Total Current Debt3 836 000
Total Equity and Debt5 093 000
Cash flow (NOK)2022
Sales Income1 454 000
Other Income5 114 000
Revenue6 568 000
Cost of Goods Sold0
Salary Costs2 646 000
Depreciation11 000
Impairment0
Expenditure4 687 000
Operating Profit1 881 000
Financial Income1 000
Financial Costs12 000
Financial Balance−11 000
Dividends3 090 000
Net Income1 459 000
Balance details (NOK)2022
Goodwill0
Total Intangible Assets0
Real Eastate0
Machinery and Plant Facilities0
Fixtures24 000
Total Tangible Assets24 000
Total Fiancial Fixed Assets242 000
Total Fixed Assets266 000
Stock0
Total Investments0
Cash, Bank127 000
Total Current Assets4 827 000
Total Assets5 093 000
Total Equity956 000
Short-Term Group Debt0
Total Long-Term Debt300 000
Creditors6 000
Unpaid Taxes159 000
Dividends3 090 000
Other Current Debt171 000
Total Current Debt3 836 000
Total Equity and Debt5 093 000
Financial indicators2022
Return on Equity152,62 %
Debt-to-Equity Ratio0,31
Operating Profit Margin28,64 %
Current Ratio1,26
Quick Ratio1,26
Equity Ratio0,19
Gross Profit Margin100 %
RotateRotate your device to see the full table
HomeIndustriesNew CompaniesAbout
🇳🇴Norsk🇬🇧English